Market Research Logo

Hungary Pharmaceuticals & Healthcare Q2 2019

Hungary Pharmaceuticals & Healthcare Q2 2019

Key View:

We hold a subdued outlook for the Hungarian pharmaceutical market in the coming years, forecasting growth to beamong the slowest five in the Central and Eastern European (CEE) region. Medicine sales will be driven by the country’s growingpensionable population and high obesity rates, contributing to a greater burden of chronic diseases which require advancedtreatments. However, with an ageing population coupled with a declining workforce, the Hungarian government will face rising costpressures and a difficult revenue raising environment over the long term. Government encouragement of generic medicines andpricing pressures, combined with patent expirations, will depress overall prescription growth values.

Key View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Hungary Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Egis Pharmaceuticals (Servier)
Gedeon Richter
Hungary Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report